359 related articles for article (PubMed ID: 8231253)
1. Infection of leukaemic B lymphocytes by Epstein Barr virus.
Doyle MG; Catovsky D; Crawford DH
Leukemia; 1993 Nov; 7(11):1858-64. PubMed ID: 8231253
[TBL] [Abstract][Full Text] [Related]
2. Induction of latent membrane protein expression in in vitro Epstein-Barr virus-infected leukaemic B lymphocytes by interleukin 4 and antibodies to CD40.
Crawford DH; Thomas JA; Gregory CD; Catovsky D; Chaggar K
Leukemia; 1995 May; 9(5):747-53. PubMed ID: 7539512
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines.
Wendel-Hansen V; Sällström J; De Campos-Lima PO; Kjellström G; Sandlund A; Siegbahn A; Carlsson M; Nilsson K; Rosén A
Leukemia; 1994 Mar; 8(3):476-84. PubMed ID: 8127151
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
Allday MJ; Crawford DH; Griffin BE
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
6. Activation and immortalization of leukaemic B cells by Epstein-Barr virus.
Walls EV; Doyle MG; Patel KK; Allday MJ; Catovsky D; Crawford DH
Int J Cancer; 1989 Nov; 44(5):846-53. PubMed ID: 2555307
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle.
Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm T; Klein E
J Hum Virol; 2000; 3(3):125-36. PubMed ID: 10881992
[TBL] [Abstract][Full Text] [Related]
10. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
11. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells, T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1.
Peng M; Lundgren E
Leukemia; 1993 Jan; 7(1):104-12. PubMed ID: 8093369
[TBL] [Abstract][Full Text] [Related]
12. [Studies on transforming functions of Epstein-Barr virus-specific proteins].
Kinoshita T
Hokkaido Igaku Zasshi; 1990 Jul; 65(4):362-75. PubMed ID: 2172130
[TBL] [Abstract][Full Text] [Related]
13. Human B cells on their route to latent infection--early but transient expression of lytic genes of Epstein-Barr virus.
Kalla M; Hammerschmidt W
Eur J Cell Biol; 2012 Jan; 91(1):65-9. PubMed ID: 21450364
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
15. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
16. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Epstein-Barr virus with leukaemic B cells in vitro. I. Abortive infection and rare cell line establishment from chronic lymphocytic leukaemic cells.
Rickinson AB; Finerty S; Epstein MA
Clin Exp Immunol; 1982 Nov; 50(2):347-54. PubMed ID: 6295671
[TBL] [Abstract][Full Text] [Related]
18. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Peng M; Lundgren E
Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
[TBL] [Abstract][Full Text] [Related]
19. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures.
Cuomo L; Trivedi P; Wang F; Winberg G; Klein G; Masucci MG
Eur J Immunol; 1990 Oct; 20(10):2293-9. PubMed ID: 2173662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
